Sjögren’s Syndrome News

In this episode, Dr. Benjamin Claytor walks us through his approach to suspected sensory ganglionopathies. I also cover other neurologic complications of Sjogren’s syndrome and some interesting history on vitamin B6.

A sensational (or lack thereof) series on the signs and symptoms of the spellbinding sensory ganglionopathies.

PHILADELPHIA — Results of a phase 2 proof-of-concept study showed that an oral Bruton’s tyrosine kinase inhibitor demonstrates trends toward efficacy in Sjögren's syndrome, according to data presented at ACR Convergence 2022.

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.

Exposure to fine particulate matter — specifically particles 2.5 µm or less in diameter, or PM2.5 — in the air signals a higher risk for systemic autoimmune rheumatic diseases, according to data published in Arthritis Research & Therapy.

Dry eye in Sjögren’s syndrome remains “underdiagnosed and undertreated,” and often not fully understood, according to Sjögren Europe, which is gearing up for World Sjögren’s Day on July 23 with a campaign aimed at raising awareness online.

SAN FRANCISCO — New real-world data demonstrate treatment with selexipag improved outcomes in patients with pulmonary arterial hypertension associated with connective tissue disease.

DESTIN, Fla. — Although not currently curable, the symptoms of Sjögren’s syndrome, like dry eyes and dry mouth, can be effectively managed using a variety of therapies, said a speaker said at the Congress of Clinical Rheumatology East 2022 meeting.

DESTIN, Fla. — Myriad symptoms and three different sets of classification criteria make Sjögren's syndrome a challenging diagnosis, according to a presenter at the Congress of Clinical Rheumatology East.